Author:
Samir Motawy M.,Salfiti R.,Khalifa F.,Fayyaz S.,Baker H.
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology,Oncology
Reference13 articles.
1. Novae RF, Kharasch ED. Mitoxantrone: propensity for free radical formation and lipid peroxidation – Implications for cardiac toxicity. Invest New Drugs 1985; 3: 101–107.
2. Arlin ZA, Silver R, Cassileth P et al: Phase I-II trial of mitoxantrone in acute leukaemia. Cancer Treat Rep 1985; 69(1): 61–64.
3. Ehninger G, Ho AD, Meyer P, Mjaaland I, Ostendorf P, Seither E: Mitoxantrone in the treatment of relapsed and refractory acute leukaemia (Abstract). Onkologie 1985; 8(3): 146–148.
4. Masaoka T, Shibata H, Oguma S et al: A phase II study of mitoxantrone in acute leukaemia (Abstract). Invest New Drugs 1985; 3(2): 197–201.
5. Moore JO, Olsen GA: Mitoxantrone in the treatment of relapsed and refractory acute leukaemia. Semin Oncol 1984; 11 (3 suppl): 41–46.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献